The global postoperative pain management market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing incidence of chronic pain and rising geriatric population. The acute pain management segment accounted for the largest share in the global postoperative pain management market in 2018, followed by moderate and severe pain management segments.
The global postoperative pain management market is segmented on the basis of type, application, and region. On the basis of type, it can be classified into acute pain management, moderate pain management, and severe pain management segments; on the basis of application it can be classified into cancer-related pains (e.g., chemotherapy-induced neuropathic pains), arthritic pains (e.g., osteoarthritis), neuropathic pains (e.g., diabetic neuropathy), musculoskeletal pains (e.g., low backache), migraine; on the basis of region it can be classified into North America (US), Latin America (Mexico & Brazil) Europe (Germany & France) Asia Pacific & Middle East Africa).
-The global population is aging, which will lead to an increase in the number of surgeries performed.
-The global population is also growing, which will lead to an increase in the number of surgeries performed.
-There are more surgical procedures being done than ever before, which will lead to an increase in the number of surgeries performed.
-There are more surgical procedures being done than ever before, leading to a need for postoperative pain management.
Industry Growth Insights published a new data on “Postoperative Pain Management Market”. The research report is titled “Postoperative Pain Management Market research by Types (Acute Pain Management, Moderate Pain Management, Severe Pain Management), By Applications (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine, Others), By Players/Companies Teva Pharmaceutical Industries Ltd., Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Baxter International Inc., Valeant Pharmaceuticals International Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Postoperative Pain Management Market Research Report
By Type
Acute Pain Management, Moderate Pain Management, Severe Pain Management
By Application
Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine, Others
By Companies
Teva Pharmaceutical Industries Ltd., Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Baxter International Inc., Valeant Pharmaceuticals International Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Postoperative Pain Management Market Report Segments:
The global Postoperative Pain Management market is segmented on the basis of:
Types
Acute Pain Management, Moderate Pain Management, Severe Pain Management
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly
- Pfizer
- Johnson & Johnson
- Purdue Pharma
- Endo Pharmaceuticals Plc.
- Forest Laboratories Inc.
- GlaxoSmithKline Plc.
- F. Hoffmann-La Roche Ltd.
- Baxter International Inc.
- Valeant Pharmaceuticals International Inc.
Highlights of The Postoperative Pain Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acute Pain Management
- Moderate Pain Management
- Severe Pain Management
- By Application:
- Cancer Pain
- Arthritic Pain
- Neuropathic Pain
- Musculoskeletal Pain
- Migraine
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postoperative Pain Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Postoperative pain management is the process of managing pain after surgery. It includes prescribing medications, providing physical therapy, and monitoring patients' progress.
Some of the major companies in the postoperative pain management market are Teva Pharmaceutical Industries Ltd., Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals Plc., Forest Laboratories Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Baxter International Inc., Valeant Pharmaceuticals International Inc..
The postoperative pain management market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Postoperative Pain Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Postoperative Pain Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Postoperative Pain Management Market - Supply Chain
4.5. Global Postoperative Pain Management Market Forecast
4.5.1. Postoperative Pain Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Postoperative Pain Management Market Size (000 Units) and Y-o-Y Growth
4.5.3. Postoperative Pain Management Market Absolute $ Opportunity
5. Global Postoperative Pain Management Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Postoperative Pain Management Market Size and Volume Forecast by Type
5.3.1. Acute Pain Management
5.3.2. Moderate Pain Management
5.3.3. Severe Pain Management
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Postoperative Pain Management Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Postoperative Pain Management Market Size and Volume Forecast by Application
6.3.1. Cancer Pain
6.3.2. Arthritic Pain
6.3.3. Neuropathic Pain
6.3.4. Musculoskeletal Pain
6.3.5. Migraine
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Postoperative Pain Management Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Postoperative Pain Management Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Postoperative Pain Management Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Postoperative Pain Management Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Postoperative Pain Management Demand Share Forecast, 2019-2029
9. North America Postoperative Pain Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Postoperative Pain Management Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Postoperative Pain Management Market Size and Volume Forecast by Application
9.4.1. Cancer Pain
9.4.2. Arthritic Pain
9.4.3. Neuropathic Pain
9.4.4. Musculoskeletal Pain
9.4.5. Migraine
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Postoperative Pain Management Market Size and Volume Forecast by Type
9.7.1. Acute Pain Management
9.7.2. Moderate Pain Management
9.7.3. Severe Pain Management
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Postoperative Pain Management Demand Share Forecast, 2019-2029
10. Latin America Postoperative Pain Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Postoperative Pain Management Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Postoperative Pain Management Market Size and Volume Forecast by Application
10.4.1. Cancer Pain
10.4.2. Arthritic Pain
10.4.3. Neuropathic Pain
10.4.4. Musculoskeletal Pain
10.4.5. Migraine
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Postoperative Pain Management Market Size and Volume Forecast by Type
10.7.1. Acute Pain Management
10.7.2. Moderate Pain Management
10.7.3. Severe Pain Management
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Postoperative Pain Management Demand Share Forecast, 2019-2029
11. Europe Postoperative Pain Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Postoperative Pain Management Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Postoperative Pain Management Market Size and Volume Forecast by Application
11.4.1. Cancer Pain
11.4.2. Arthritic Pain
11.4.3. Neuropathic Pain
11.4.4. Musculoskeletal Pain
11.4.5. Migraine
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Postoperative Pain Management Market Size and Volume Forecast by Type
11.7.1. Acute Pain Management
11.7.2. Moderate PainManagement
11.7.3. Severe Pain Management
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Postoperative Pain Management Demand Share, 2019-2029
12. Asia Pacific Postoperative Pain Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Postoperative Pain Management Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Postoperative Pain Management Market Size and Volume Forecast by Application
12.4.1. Cancer Pain
12.4.2. Arthritic Pain
12.4.3. Neuropathic Pain
12.4.4. Musculoskeletal Pain
12.4.5. Migraine
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Postoperative Pain Management Market Size and Volume Forecast by Type
12.7.1. Acute Pain Management
12.7.2. Moderate Pain Management
12.7.3. Severe Pain Management
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Postoperative Pain Management Demand Share, 2019-2029
13. Middle East & Africa Postoperative Pain Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Postoperative Pain Management Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Postoperative Pain Management Market Size and Volume Forecast by Application
13.4.1. Cancer Pain
13.4.2. Arthritic Pain
13.4.3. Neuropathic Pain
13.4.4. Musculoskeletal Pain
13.4.5. Migraine
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Postoperative Pain Management Market Size and Volume Forecast by Type
13.7.1. Acute Pain Management
13.7.2. Moderate Pain Management
13.7.3. Severe Pain Management
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Postoperative Pain Management Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Postoperative Pain Management Market: Market Share Analysis
14.2. Postoperative Pain Management Distributors and Customers
14.3. Postoperative Pain Management Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva Pharmaceutical Industries Ltd.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eli Lilly
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Purdue Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Endo Pharmaceuticals Plc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Forest Laboratories Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GlaxoSmithKline Plc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. F. Hoffmann-La Roche Ltd.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Baxter International Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Valeant Pharmaceuticals International Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
